FDA — authorised 20 November 2020
- Marketing authorisation holder: EIGER BIOPHARMACEUTICALS INC
- Status: approved
🇺🇸 Zokinvy in United States
FDA authorised Zokinvy on 20 November 2020
Marketing authorisations
FDA — authorised 20 November 2020
- Application: NDA213969
- Marketing authorisation holder: SENTYNL THERAPS INC
- Local brand name: ZOKINVY
- Indication: CAPSULE — ORAL
- Status: approved
Zokinvy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Zokinvy approved in United States?
Yes. FDA authorised it on 20 November 2020; FDA authorised it on 20 November 2020.
Who is the marketing authorisation holder for Zokinvy in United States?
EIGER BIOPHARMACEUTICALS INC holds the US marketing authorisation.